Search Results - "Ralefala, Tlotlo B."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana by Davey, Sonya, Grover, Surbhi, Bilker, Warren B, Setlhako, Dipho I, Ralefala, Tlotlo B, Manshimba, Patrick, Gross, Robert, DeMichele, Angela, Shulman, Lawrence N, Martei, Yehoda M

    Published in BMJ open (12-07-2021)
    “…ObjectiveCancer drug stockouts occur at high frequencies globally, however, their effects on treatment are understudied in sub-Saharan Africa (SSA). We aimed…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    A retrospective study of stage IB node-negative cervical cancer treated with adjuvant radiation with standard pelvic versus central small pelvic fields by Van Wijk, Leon, Saidu, Rakiya, Ralefala, Tlotlo B.

    “…Objective: To compare two types of postoperative radiation therapy (PORT) in early-stage, node-negative cervical cancer treated at Groote Schuur Hospital, Cape…”
    Get full text
    Journal Article
  9. 9

    Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting by Martei, Yehoda M, Grover, Surbhi, Bilker, Warren B, Monare, Barati, Setlhako, Dipho I, Ralefala, Tlotlo B, Manshimba, Patrick, Gross, Robert, Shulman, Lawrence N, DeMichele, Angela

    Published in Journal of global oncology (10-04-2019)
    “…Essential cancer medicine stock outs are occurring at an increasing frequency worldwide and represent a potential barrier to delivery of standard therapy in…”
    Get full text
    Journal Article
  10. 10

    Ensuring Global Access to Cancer Medicines: A Generational Call to Action by Dare, Anna J, Bayle, Arnauld, Hatoqai, Asma, Mungo, Chemtai, Velilla, Diego Gimenez, Soto-Perez-de-Celis, Enrique, Gnangnon, Freddy Houéhanou Rodrigue, Lim, Melissa Siaw Han, Ralefala, Tlotlo, Mushininga, Venus Dadirai

    Published in Cancer discovery (06-02-2023)
    “…Essential cancer treatments are not accessible, affordable, or available to patients who need them in many parts of the world. A new Access to Oncology…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13